This liver disease develops because the liver has difficulty breaking down fats, causing a buildup in the tissue and hampering its functions.

Approximately 30 percent of American adults are affected by non-alcoholic fatty liver disease (NAFLD). Of this number, approximately 20 percent have developed progressive non-alcoholic steatohepatitis (NASH), which may lead to cirrhosis. Groups more prone to NASH include obese men with type 2 diabetes, Asians, South Sea Islanders and Latin Americans. Genetics may be another factor in the rapid development of NASH.

Symptoms of Fatty Liver Disease

Often, patients don’t have noticeable symptoms of fatty liver disease. It is most commonly found through elevated liver enzymes when routine blood work is done. Fatty liver disease is often linked to:

  • Insulin resistance: Diminishment of the cells’ ability to respond to insulin when insulin transports glucose (sugar) from the bloodstream into muscle and other tissues
  • High levels of triglycerides, a type of fat, in your blood
  • Low levels of HDL, the good cholesterol, in your blood
  • Too much fat around your waist
  • High blood pressure

Fatty Liver Disease Treatment

Our metabolic liver clinic provides multidisciplinary treatment for patients with NAFLD. We partner closely with experts in bariatric surgery, endocrinology and nutrition to create a personalized treatment plan to help you manage your disease.

  • Lifestyle modification – This is the best defense against NAFLD symptoms. Our comprehensive wellness program will help provide you with weight management and nutrition tools to help alleviate symptoms of fatty liver disease.
  • Medications
  • Clinical trials

Fibroscan, a noninvasive and painless treatment, is ideal for patients with nonalcoholic fatty liver disease.

Ohio State's Tailored Patient Approach to Fatty Liver Disease

Treatment of Fatty Liver Disease, Obesity and Type 2 Diabetes

Our Providers

Share this Page